admin

Jonathan Gilbert of Roslyn Heights (right) with Gillian Hotz, a professor of neurosurgery at the University of Miami’s Miller School of Medicine. (Photo courtesy of Jonathan Gilbert) Jonathan Gilbert’s oldest son, Jake, a senior at the Wheatley School, started a nonprofit to support Tourette syndrome research after his younger brother, Kane, was diagnosed with the […]

by

WASHINGTON — Healthcare providers need more education and openness about the role of medical cannabis for treating chronic pain, including possible combinations with prescription opioids, advocates said here. “It really goes at the heart of educating physicians. Opioids with cannabis can be a much better tool for fighting pain [than opioids alone], and doctors should […]

by

LAGUNA HILLS, Calif., April 10, 2017 — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that its research partner, the University of Northern Colorado (UNC), has made significant progress with PharmaCyte’s Cannabis Research Program. Of note, […]

by

Positive health outcomes like opioid replacement aren’t the only changes researchers will be tracking after legalization. “The obvious thing in Canada would be to monitor for things like hospital admissions for psychosis and schizophrenia,” says Robin Murray, a professor of psychiatric research at King’s College London. Cannabis is very safe in the patterns most adults […]

by

Research led by University of Northern Colorado Professor Richard Hyslop is making significant progress in developing a targeted cancer treatment using cannabinoids as a chemotherapy agent, according to a news release issued Monday. The UNC research has concentrated on the feasibility of developing cells capable of producing an enzyme that can convert inactive cannabis compounds […]

by

SAN DIEGO, CA–(Marketwired – Apr 10, 2017) –  MyDx, Inc. ( OTCQB : MYDX ), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for the Cannabis professional and retail consumer to correlate the chemical profile of cannabis with how it makes consumers feel and what […]

by

TORONTO, ON–(Marketwired – April 10, 2017) – Today, Canabo Medical Inc. (TSX:CMM) (OTCQB:CAMDF) (“Canabo” or the “Company”) released the results of a new, landmark observational study that connects doctor-supervised medical cannabis treatments to a sharp drop in benzodiazepine reliance among Canadian patients. Research conducted over the past year revealed that 40 per cent of patients […]

by

Updated April 10, 2017 12:11:46 Photo: The states are still catching up after federal changes to medicinal cannabis. (Image supplied: AusCann) The lawyer for a South Australian woman who admits to supplying cannabis oil to terminally ill people has questioned why charges against her client have only recently been laid. Hillier resident Jenny Hallam’s home […]

by

PETACH TIKVA, Israel, April 5, 2017 /PRNewswire/ — OWC Pharmaceutical Research Corp. (OWCP), (“OWC” or the “Company”), an Israeli-based research company engaged in the development of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced it has received expressions of interest from the scientific and medical communities world-wide as a result […]

by

Positive health outcomes like opioid replacement aren’t the only changes researchers will be tracking after legalization. “The obvious thing in Canada would be to monitor for things like hospital admissions for psychosis and schizophrenia,” says Robin Murray, a professor of psychiatric research at King’s College London. Cannabis is very safe in the patterns most adults […]